Skip to main content
. 2021 Jul 22;142:104931. doi: 10.1016/j.jcv.2021.104931

Fig. 2.

Fig 2

A: Percentage sensitivity with 95% CI of the different tests according to days from symptoms onset investigated during the extended phase of the evaluation. B: Corresponding Forest plots of the sensitivity at > 15 days post-symptom onset with the corresponding 95% CI. C: Forest plots of the specificity with the corresponding 95% CI.